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Almost 20 years ago, the discovery that mitochondrial
release of cytochrome c initiates a cascade that leads
to cell death brought about a wholesale change in
how cell biologists think of mitochondria. Formerly
viewed as sites of biosynthesis and bioenergy
production, these double membrane organelles
could now be thought of as regulators of signal
transduction. Within a few years, multiple other
mitochondria-centric signaling mechanisms have
been proposed, including release of reactive oxygen
species and the scaffolding of signaling complexes on
the outer mitochondrial membrane. It has also been
shown that mitochondrial dysfunction causes
induction of stress responses, bolstering the idea that
mitochondria communicate their fitness to the rest of
the cell. In the past decade, multiple new modes of
mitochondrial signaling have been discovered. These
include the release of metabolites, mitochondrial
motility and dynamics, and interaction with other
organelles such as endoplasmic reticulum in regulating
signaling. Collectively these studies have established
that mitochondria-dependent signaling has diverse
physiological and pathophysiological outcomes.
This review is a brief account of recent work in
mitochondria-dependent signaling in the historical
framework of the early studies.rest of the cell and thus have signaling functions beyondHans Krebs won the Nobel Prize in Physiology or Medi-
cine in 1953 for his discovery of the citric acid cycle. In
his Nobel Lecture, Krebs stated, ‘that in some micro-
organisms the cycle primarily supplies intermediates ra-
ther than energy, whilst in the animal and most other
organisms it supplies both energy and intermediates’.
This essentially describes the two salient functions of
mitochondria described in most biochemistry textbooks:
production of ATP, and the generation of intermediaryCorrespondence: nav@northwestern.edu
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reproduction in any medium, provided the ormetabolites. The citric acid cycle, commonly referred to
as the TCA cycle, generates metabolites and reducing
equivalents (NADH and FADH2). Electrons from redu-
cing equivalents feed into the mitochondrial electron
transport chain (ETC), which pumps protons across the
mitochondrial inner membrane to generate an electro-
chemical gradient that is required both for production of
ATP and for the efficient shuttling of proteins into and
out of mitochondria. Mitochondrial ATP generation
allows cells to maintain a high ATP/ADP ratio, which is
necessary to thermodynamically drive many biochemical
reactions. Mitochondria are also involved in the gener-
ation of proteins that contain heme and porphyrin moi-
eties, a process dependent on membrane potential. The
metabolites generated by the TCA cycle are precursors
to the biosynthesis of many macromolecules, including
lipids, carbohydrates, proteins and nucleotides. Thus,
mitochondria have historically been viewed as bioener-
getic and biosynthetic organelles; however, mitochondrial
genetics has demonstrated that alterations in proteins
that have similar effects on TCA cycle and ETC activity
often yield divergent phenotypes, suggesting that mito-
chondrial perturbation must manifest beyond biosyn-
thesis and bioenergetics.
In the past two decades, the reason for this has be-
come clear, as it has been increasingly appreciated that
mitochondria have developed mechanisms to communi-
cate their biosynthetic and bioenergetics fitness to the
their metabolic ones (Figure 1). One critical function of
these is to ensure that cells do not become committed
to a biological process without input on the fitness of
mitochondria, risking a discrepancy between the meta-
bolic demands of the cell and the ability of the mito-
chondria to meet them. In the 1990s, multiple groups
pioneered the idea that mitochondria communicate with
the cytosol. Their observations included (1) mitochon-
drial release of cytochrome c to initiate cell death [1];
(2) mitochondrial release of reactive oxygen species (ROS)
to activate hypoxic gene expression [2]; (3) the localization
of A-kinase-anchoring proteins (AKAPs) to the mitochon-
drial outer membrane, allowing cAMP-dependent proteinThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1. Three essential functions of mitochondria. Mitochondria
have three distinct functions in the maintenance of homeostasis:
bioenergetics, biosynthesis, and signaling.
Figure 2. Mitochondria regulate signaling. Mitochondria regulate
signaling pathways through release of cytochrome c to invoke
caspase-dependent cell death, release of reactive oxygen species (ROS)
to induce gene expression, and the use their outer membranes as a
scaffold for signaling complexes, notably immune responses and
control of cell death.
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mitochondrial membrane [3,4]; and (4) mitochondrial
dysfunction causing induction of mitochondria-specific
heat shock proteins and promoting cytosolic calcium-
dependent signaling [5,6].
These studies led to the emerging concept that mito-
chondria are signaling organelles either through the re-
lease of proteins, ROS, or metabolites, or by serving as a
scaffold to configure signaling complexes (Figure 2). In
the new millennium, multiple other mechanisms have
been uncovered by which mitochondria communicate
with the rest of the cell. Signal transduction from mito-
chondria to the cytosol is referred to as retrograde signal-
ing and signal transduction from cytosol to mitochondria
as anterograde signaling, and the insights of the 1990s
included those emerging from studies on anterograde
signaling, most notably through cytosolic calcium enter-
ing into mitochondria to regulate bioenergetics [7].
In this review, however, I will discuss only the retro-
grade signaling mechanisms whereby mitochondria
communicate with the cell under physiological and
pathological conditions.
Mitochondrial cytochrome c release regulates
signaling
In the mid-1990s, the biology related to mitochondrial
genetics was an exciting and rapidly evolving field.
Mitochondria contain their own genome, which encodes
a small percentage of mitochondrial proteins, with the
majority encoded by nuclear DNA. How mitochondrial
DNA integrates with nuclear DNA to make cells func-
tion and how miscommunication between the two types
of DNA can lead to pathology continues to be a fascinat-
ing question [8]. By contrast, there was a sense that
every question related to the biochemistry of mitochon-
dria had been answered. The field’s best days were in the
past. Nevertheless, I had pursued a PhD on the oxygendependence of cytochrome c oxidase [9,10] because I
thought there might be interesting biochemistry under
limiting oxygen conditions (hypoxia), a condition prom-
inent in tumors, ischemic diseases and during develop-
ment in utero. Thus, it came as a complete surprise
when in 1996 Xiaodong Wang and colleagues, using
biochemical approaches, reported that cytochrome c is
released from mitochondria to initiate cell death in
mammalian cells [1]. Cytochrome c is an electron carrier
in the mitochondria and is an essential component of
the electron transport chain, and ultimately necessary
for ATP generation. To me, this seemed an extraordinar-
ily important discovery in research on mitochondria. It
reenergized interest not only in the biochemical activ-
ities of mitochondria, but also in how this organelle is
integrated with the rest of the cell. Soon multiple labs
around the world were examining the mechanisms lead-
ing to release of cytochrome c in cells that have been
instructed to die [11-13]. This led to the examination of
mitochondrial ATP generation, membrane potential, and
oxygen consumption in cells committed to death - all of
which were things I understood. But, beyond its seminal
role in cell death, the discovery of the apoptotic release
of cytochrome c opened the possibility that there might
be other mechanisms by which mitochondria communi-
cate with the cell, especially under physiological condi-
tions. It was difficult to imagine that mitochondria
would play a signaling role only under conditions leading
to cell death.
Mitochondrial ROS regulate signaling
In the mid-1990s, NADPH oxidase activity had been
demonstrated to promote signaling pathways involved in
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residues in proteins, modulating their activity [14-16].
By contrast, mitochondrial ROS (mROS) were proposed
to be produced only under pathological conditions to in-
voke damage [17]. However, in the late 1990s, mROS
emerged as signaling molecules that communicate
between mitochondria and the rest of the cell under
physiological conditions. An early example of this retro-
grade signaling under physiological conditions is the
observation that hypoxic conditions stimulate mitochon-
dria to release ROS, resulting in the stabilization of hyp-
oxia inducible factors (HIFs) and the induction of genes
responsible for metabolic adaptation to low oxygen
[2,18]. Subsequently, mROS were shown to regulate cel-
lular metabolism and tumor necrosis factor receptor sig-
naling [19-21]. Eight sites in the mitochondrial inner
membrane and matrix have been implicated in the pro-
duction of ROS [22]. The factors that control mROS
production include the concentration of oxygen available
to mitochondria, the redox state of the different electron
transport chain complexes and mitochondrial membrane
potential [23]. In the past decade, mROS have been
shown to regulate a wide range of biological processes,
including oxygen sensing, epigenetics, autophagy, innate
and adaptive immune responses, stem cell proliferation
and differentiation, and hormone signaling [24-28].
A scientific colleague and friend once quipped, ‘If you
don’t have a mechanism just say it is ROS’. There is
some justification for this remark, since ROS have been
linked to a wide variety of biological outcomes, includ-
ing proliferation, differentiation, metabolic adaptation
and senescence, though with no insight into the specific
mROS targets required to invoke such diverse biological
outcomes, or the mechanism involved. It is important to
note that mROS targets that relay signaling could be lo-
calized in any or all of the mitochondrial matrix, the in-
termembrane space, or the cytosol. Furthermore, given
the reactivity and toxicity of ROS at high levels, it seems
likely that lower levels of mROS may be generated that
invoke distinct biological outcomes. Control of different
stem cell fates by ROS is an example of different levels
of ROS invoking different biological outcomes. The two
salient features of stem cells are their ability to self-
renew, and their ability to differentiate into specialized
tissues [29,30]. An emerging model is that quiescent
stem cells reside at low levels of ROS and slight in-
creases in ROS are necessary signals for self-renewal and
cellular differentiation [31-33]. ROS levels above those
required for self-renewal or differentiation impair these
critical two stem cell properties and result in stem cell
hyper-proliferation, resulting in stem cell exhaustion
[34]. Going forward, it will be important to systematic-
ally quantify the ROS levels generated by mitochondria
and their targets that are necessary for stem cellproliferation, differentiation and exhaustion in a given
stem cell model system.
One interesting development over the past two de-
cades has been the change in perspective on the role of
mROS signaling in aging. Originally the free radical the-
ory of aging proposed that, during the aging process,
damaged mitochondria produced increasing amounts of
ROS leading to tissue damage [35]. However, in most
studies antioxidants have not extended lifespan of model
organisms and clinical trials using antioxidants in
humans have not shown any beneficial effects on age-
related diseases [36]. On the contrary, recent evidence in
yeast, Caenorhabditis elegans, and mice suggests that in-
creasing mitochondrial generation of ROS can activate
cellular stress pathways to dampen tissue degeneration,
promote healthy aging and increase lifespan [37-40].
Based on the studies from the past two decades, an
emerging model of mROS and signaling suggests that
low levels (picomolar to nanomolar range) of mROS are
necessary to maintain homeostatic biological processes,
while slightly elevated levels of mROS initiate pathways
for adaptation to stress. Much higher levels of mROS
trigger cell death or senescence.
Mitochondrial outer membrane as a platform for
signaling
In the mid-1990s it was shown that AKAPs could be
tethered to the outer mitochondrial membrane and, in
subsequent years, the targeting motifs needed for AKAP
binding to outer mitochondrial membrane were eluci-
dated [4,41]. AKAPs bind to the cAMP-dependent
serine/threonine kinase PKA and assemble PKA with
multiple signaling proteins on a scaffold to generate a
signaling hub, which can be targeted to various subcellu-
lar localizations to allow specific targeting of PKA-
dependent signaling [42]. The biological significance of
AKAP tethering to mitochondria was demonstrated in
the late 1990s when it was shown that survival factors
induce PKA-dependent phosphorylation and inactivation
of BAD, a proapoptotic Bcl2 family member, specifically
bound to outer mitochondrial membrane [3]. Beyond
apoptosis, recent studies demonstrate that BAD tether-
ing to mitochondria also regulates organismal glucose
homeostasis [43,44]. In the past decade, mitochondria-
bound PKA-AKAP assemblies have been shown to regu-
late oxidative metabolism, the mitochondrial fission/fu-
sion machinery, and hypoxic responses [45,46]. This
allows cellular signaling pathways to converge on the
mitochondrial PKA-AKAP axis to control mitochondrial
function. AKAPs have been shown to not only anchor
PKA, but also act as scaffolding proteins to coordinate
the activity of many other signaling enzymes such as
kinases and phosphatases [47]. Thus, it is likely that there
are multiple other AKAP-dependent but PKA-independent
Figure 3. Mitochondrial dysfunction induces stress responses
or mitophagy. Loss of mitochondrial electron transport chain
function and/or misfolded proteins in mitochondrial matrix induces
expression of genes through decreases in mitochondrial membrane
potential. Sustained loss of mitochondrial membrane potential can
invoke mitophagy, a process to eliminate dysfunctional mitochondria.
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membrane that remain to be discovered.
The mitochondrial outer membrane also serves as a
scaffold for complexes regulating immune responses. This
was first highlighted in the mid-2000s by the identification
of mitochondrial antiviral signaling protein (MAVS), a
crucial adaptor for RIG-I-like receptor signaling [48].
RIG-I recognizes single-stranded viral RNA and subse-
quently activates type I interferon production through
MAVS, which is localized to the outer mitochondrial
membrane [49,50]. Type-I interferons (IFNα/β) are
secreted very soon after virus infection. Infected cells gen-
erate IFNβ followed shortly by the production of IFNα.
Type I interferons activate interferon-stimulated genes
(ISGs) as well as the NF-κB pathway. ISGs encode anti-
viral proteins that produce an anti-viral state in surround-
ing cells in close proximity to the infected cells, to limit
the spread of the virus. The activation of the NK-κB path-
way leads to the production of several proinflammatory
cytokines and chemokines that lead to infiltration of
circulating innate cells and eventually adaptive immune T
and B cells. This helps control the viral infection [51].
Recently, other innate immune molecules involved in
NOD-like receptor (NLR) and TOLL-like receptor (TLR)
signaling have been functionally associated with the
outer mitochondrial membrane [52-54]. Exactly why
these immune complexes require localization to the
outer mitochondrial membrane is not fully under-
stood [55]. Mitochondria-generated ROS are necessary
for optimal function of many immune responses, and
thus proximity to ROS production could be one rea-
son why immune complexes are tethered to the outer
mitochondrial membrane [56,57]. It is interesting that
mitochondria are evolutionarily related to alpha-
proteobacteria, and thus are descended from symbi-
otic pathogens. We continue to be dependent on our
own pathogen - mitochondria - to mount optimal re-
sponses against foreign pathogens.
Mitochondrial dysfunction and signaling
So far I have described mitochondrial signaling in the
context of physiologic homeostasis. However, there are
conditions where mitochondria become dysfunctional.
Mitochondrial dysfunction, defined as the inability to
generate ATP or metabolites, or import/export proteins,
can arise when a substrate such as oxygen becomes lim-
iting for ETC function, or through genetic alterations
that lead to impairment of mitochondrial proteins. How
do dysfunctional mitochondria communicate with the
rest of the cell? An early clue that mitochondrial dys-
function can induce cellular responses came from the
observation in the mid-1990s that the loss of mitochon-
drial DNA can induce nuclear encoded mitochondrial
heat shock proteins (HSPs) but not cytosolic HSPs [5].In the late 1990s, decreased mitochondrial membrane
potential resulting in an increase in cytosolic calcium
was one mechanism elucidated by which loss of mito-
chondrial DNA activates signaling pathways [6]. Subse-
quent studies demonstrated that accumulation of
unfolded proteins within the mitochondrial matrix
results in the induction of mitochondria-specific HSPs, a
process referred to as the mitochondrial-unfolded
response (mtUPR) [58]. The significance of the mtUPR
began to be unraveled in the late 2000s by the discovery
of pathways that induce the mtUPR in C. elegans
[59,60]. Further studies demonstrated that activation
of the mtUPR by mitochondrial dysfunction could in-
crease lifespan in C. elegans [61,62]. Although slight
or transient mitochondrial dysfunction induces adap-
tive stress responses, sustained mitochondrial dysfunc-
tion typically leads to elimination of mitochondria by
mitophagy [63]. A given cell can contain sets of mito-
chondria that are functional and dysfunctional. The
dysfunctional mitochondria can send signals to induce
stress responses such as induction of mitochondrial
HSPs until mitophagy eliminates them (Figure 3). Im-
pairment of mitophagy can result in accumulation of
dysfunctional mitochondria and disruption of calcium
homeostasis, overproduction of ROS, and loss of me-
tabolite and ATP production, all leading to the de-
mise of the cell [64,65].
Emerging modes of communication between
mitochondria and the cell
In the past few years, other interesting modes of com-
munication between mitochondria and the rest of the
Figure 4. Emerging modes of mitochondria-dependent
signaling. Mitochondrial production of metabolites and
mitochondrial dynamics (motility and fission/fusion) regulate
signaling. Mitochondrial interaction with specific subdomains of the
endoplasmic reticulum (ER), referred to as mitochondria-associated
membranes or MAMs, are emerging as important regulators of
signaling transduction.
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metabolites, activation of AMPK, and changes in mito-
chondrial dynamics. Briefly I will highlight these lively
new areas. Metabolite availability has emerged as an
important mechanism to control signal transduction,
notably the acetylation and methylation of DNA and his-
tones regulating epigenetics [66]. Mitochondria generate
much of the acetyl-CoA and S-Adenosylmethionine
(SAM) needed for protein acetylation and methylation,
respectively. Thus, changes in mitochondrial biology can
have profound effects on the epigenetic state [67-69].
Metabolic enzymes can also undergo acetylation at spe-
cific residues that affect their catalytic function [70].
Loss of ATP production by mitochondria (for example,
during ischemia) can also regulate signaling through
increasing levels of AMP and its breakdown product
adenosine. The increase in AMP levels concomitant with
a decrease in ATP levels activates the kinase AMPK,
which halts multiple anabolic processes (metabolic
demand) in the cell and promotes catabolic processes
such as autophagy to ensure ample metabolic supply
[71]. Adenosine can be released from cells where it
engages in activation of G-protein-coupled receptors
[72,73]. Thus, metabolites and adenine nucleotides
typically thought of being involved in biosynthetic and
bioenergetic processes are also actively involved in
signaling.
The cell biology of mitochondria has rapidly evolved
in the past decade, bringing about the new field of mito-
chondrial dynamics [74]. While the molecular details of
how mitochondria move throughout the cell are still
being elucidated, it is known that the ability of mito-
chondria to properly move around in the cell is required
to properly disseminate their signals to the correct
targets [75]. For example, hypoxia causes mitochondria
to cluster into the perinuclear region, allowing release of
ROS into the nucleus for optimal hypoxic gene expres-
sion [76]. Mitochondria in healthy cells tend to be elon-
gated and fuse together into ‘spaghetti’ like filamentous
structures. The rate of fusion and fission of mitochon-
dria is tightly controlled [77]. Excessive fission disrupts
these filamentous networks, resulting in a punctate
pattern and mitochondrial dysfunction. A recent study
highlights how the fission/fusion machinery integrates
with cellular signaling to dictate biological outcomes.
The disruption of fusion in mouse embryonic heart and
in embryonic stem cells results in disruption of mouse
heart development and impaired differentiation of
embryonic stem cells into cardiomyocytes due to
increased Ca2+-dependent calcineurin activity and
Notch1 signaling [78].
Lastly, mitochondria tether to specific subdomains
of the endoplasmic reticulum (ER) referred to as
mitochondria-associated membranes or MAMs [79].Initially, MAMs were shown to be necessary for rapid
transmission of calcium (Ca2+) signals between the
ER and mitochondria to regulate intracellular calcium
levels [80]. Recent studies have demonstrated that
MAMs regulate mitochondrial motility and shape,
ROS and ATP production, autophagy, ER stress and
immune signaling [81].
All these modes of communication are summarized in
Figure 4.Conclusion
In the past decade, there has been an explosion of
scientific inquiry in the areas of mitochondrial genet-
ics, cell biology and biochemistry [82]. Work in
these fields is increasingly converging on the control
of signaling events in the rest of the cell, with im-
portant implications for regulation of physiology and
common diseases. Although much has been deci-
phered about the types of signaling modes whereby
mitochondria communicate with the rest of the cell,
the molecular details remain sparse. A better under-
standing of the underlying mechanisms will hopefully
yield insight into how to alleviate common diseases
such as diabetes, cancer, and neurodegeneration, as
well as provide insight into the early evolution of
eukaryotes.
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